This week’s insider trading roundup spotlights key stock purchases and sales made by executives, directors, and major shareholders. The transactions below were ...

From analyst to partner, seven Goldman employees shared a look at how the bank's internal ChatGPT-like tool is making their ...

Several big banks stepped up their stock repurchases in the first quarter in a sign of confidence despite growing concern ...

Investors digested President Donald Trump’s latest tariff exemptions and looked toward a big week for first-quarter earnings.

Vaccine makers targeting COVID-19 to measles will come under investor scrutiny on Tuesday as a group of independent experts at the CDC are scheduled to meet for the first time to review U.S.

Goldman Sachs reported revenue drops in two of its three main business lines, but trading revenue was enough to satisfy ...

The company reported net income to common shareholders of $4.6 billion, or $14.12 per diluted share, on $15.1 billion of net ...

GSK's (GSK) stock rises as the company's Arexvy shot could see expanded CDC recommendations for RSV protection in at-risk adults aged 50-59 this week. Read more here.

Goldman Sachs beat first-quarter profit estimates as its traders capitalized on volatile markets to bring in record equities ...

In a report released on April 11, Salveen Richter from Goldman Sachs maintained a Buy rating on Regeneron (REGN – Research Report), with a ...